Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Completed NCT06329882

Doxycycline in Type II Diabetes

Conditions: Diabetes Mellitus, Type 2

Sex: All

Ages: 40 Years – 60 Years

Healthy volunteers: No

Phase: PHASE1, PHASE2

Enrollment: 60

Sponsor: Mostafa Bahaa

Location: Tanta Unuversity Tanta

Summary

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disease characterized by hyperglycemia, weight loss, and cardio-metabolic complications. T2DM develops due to the progression of insulin resistance (IR), impairment of insulin insensitivity, and failure of the pancreatic β-cells to release sufficient amount of insulin in response to glucose burden

Eligibility Criteria

Inclusion Criteria: * Male or female sex more than 40 years old Newly diagnosed type II diabetes. HbA1c more than 6.5 Exclusion Criteria: * Patient with chronic kidney disease, hepatic disorders, mental and psychiatric disorders, pregnancy, and lactation

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT06329882). StuddyBuddy aggregates publicly available trial information.